We hypothesize that pathways regulating CD276—a bladder cancer cell and/or stem cell marker—are distinct and regulated independently from the other cancer stem cell markers investigated—i.e., CD24, CD44, and the ALDH1 paralog A1—and independent from the regulation of cell proliferation. This evidence concerns the gene CD44 and urinary bladder cancer.